Clinical Trials Sponsored by Stöpler Belgium nv

Total 15 results

Universiteit Antwerpen
Stöpler Belgium nv

Unknown

Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.

Total Hip Arthroplasty

Belgium
Biotronik Belgium NV

Completed

BIOFLOW-III Belgium Satellite Registry

Myocardial Ischemia | Coronary Artery Disease

Belgium
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
SGS Life Sciences, a division of SGS Belgium NV

Completed

A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers

Influenza, Human
Genfit
SGS Life Sciences, a division of SGS Belgium NV

Completed

Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

Healthy

Belgium
Cytoki Pharma
SGS Life Sciences, a division of SGS Belgium NV

Completed

A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity

Healthy

Belgium
Psyadon Pharma
SGS Life Sciences, a division of SGS Belgium NV

Completed

Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue

Healthy

Belgium
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adults

Genetic Disease | Nonsense Mutation

Belgium
Vicore Pharma AB
SGS Life Sciences, a division of SGS Belgium NV

Completed

Cold Challenge With C21 in RP

Systemic Sclerosis | Raynaud Phenomenon

United Kingdom
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adult Subjects

Genetic Disease | Nonsense Mutation

Belgium
Pierre Fabre Medicament
SGS Life Sciences, a division of SGS Belgium NV

Completed

Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

Chronic Obstructive Pulmonary Disease

Belgium, France
Medicines for Malaria Venture
Sanaria Inc.; Institute of Tropical Medicine, Belgium; Iqvia Pty Ltd; SGS Life... and other collaborators

Completed

Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites

Protozoan Infections | Parasitemia | Malaria,Falciparum | Parasitic Disease

Belgium
Medicines for Malaria Venture
Washington University School of Medicine; Sanaria Inc.; Institute of Tropical... and other collaborators

Completed

Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model

Malaria

Belgium
University Hospital, Antwerp
Karolinska Institutet; Erasmus Medical Center; University of California, San... and other collaborators

Completed

CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI)

Traumatic Brain Injury

Germany, Norway, United Kingdom, Belgium, Netherlands, Denmark, Finland, Sweden, France, Switzerland, Israel, Spain, Austria, Serbia, Latvia, Hungary, Italy, Lithuania, Romania

Clinical Trials Sponsored by Stöpler Belgium nv

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations